Startup | August 25, 2021
Govt to offer incentives to support 75 start-ups in Tele-Medicine, AI and Digital Health
The aim is to give a fillip to R&D in the health sector to face the Covid-19 challenge
The aim is to give a fillip to R&D in the health sector to face the Covid-19 challenge
A total of 526 brands has seen a reduction of up to 90 per cent in MRP
NPPA also fixed retail price of 76 new drugs in the meeting dated 10th March 2021 to be launched by existing manufacturers including off-patent Anti-diabetic drugs allowing due benefit of patent expiry to the patients.
Besides powering the drug discovery efforts, phytopharmaceuticals have a huge potential to create a niche market for itself, thereby helping to expand the bio-economy.
The Macau authorization followed a regulatory review that considered prior decisions by both the US FDA) and the European Medicines Agency
The timing of the partnership is crucial, as Kerala’s fertility rate has dropped to approximately 1.35–1.7 children per woman, below the replacement level of 2.1
SNV4818, the oral drug, is pan-mutant–selective PI3K? inhibitor aimed at treating HR+/HER2- breast cancer and potentially other solid tumors
New targeted pill offers hope for adults and teens with moderate-to-severe plaque psoriasis
Capital infusion to accelerate Earendil’s R&D platform
The Institute of Human Biology (IHB) enables scientists to pioneer human model systems, accelerating the development of new medicines to improve the lives of patients
Subscribe To Our Newsletter & Stay Updated
